Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $285.2500 (-4.18%) ($282.5200 - $297.7200) on Fri. Jun. 20, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.42% (three month average) | RSI | 29 | Latest Price | $285.2500(-4.18%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.4% a day on average for past five trading days. | Weekly Trend | REGN declines -1.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XBI(38%) XLV(38%) QQQ(31%) SPY(30%) XLK(28%) | Factors Impacting REGN price | REGN will decline at least -1.21% in a week (0% probabilities). VIXM(-13%) TLT(-6%) SHY(-3%) IGOV(-3%) UUP(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.21% (StdDev 2.42%) | Hourly BBV | 0 () | Intraday Trend | -4% | | | |
|
Resistance Level | $306.12 | 5 Day Moving Average | $299.85(-4.87%) | 10 Day Moving Average | $304.52(-6.33%) | 20 Day Moving Average | $306.12(-6.82%) | To recent high | -13.2% | To recent low | 2.1% | Market Cap | $30.245b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |